Humana (HUM) Medicare Advantage president granted 8,206 RSUs in award

Rhea-AI Filing Summary

Humana Inc. executive Aaron Martin received a grant of 8,206 shares of Humana common stock as a compensation award. The award was recorded at a price of $0.0000 per share and classified as a grant or other acquisition rather than an open-market purchase.

Following this transaction, Martin directly holds 25,237 restricted stock units, each representing a contingent right to receive one share of Humana Inc. common stock. These units were granted under the company’s 2019 Amended & Restated and 2026 Stock Incentive Plans and are exempt under Rule 16b-3.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Martin Aaron

Role President, Medicare Advantage

Type	Security	Shares	Price	Value
Grant/Award	Humana Common	8,206	$0.00	--

Holdings After Transaction: Humana Common — 25,237 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 8,206 shares Grant price: $0.0000 per share Total RSUs held after grant: 25,237 units

3 metrics

Shares granted 8,206 shares Grant of Humana common stock on May 1, 2026

Grant price $0.0000 per share Recorded transaction price for the award

Total RSUs held after grant 25,237 units Restricted stock units representing Humana common stock

Key Terms

restricted stock units, Rule 16b-3, Stock Incentive Plans

3 terms

restricted stock units financial

"Includes 25,237 restricted stock units representing a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 16b-3 regulatory

"exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

Stock Incentive Plans financial

"under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans"

Stock incentive plans are programs that pay employees, executives or directors with company shares or options to buy shares instead of—or in addition to—cash. They matter to investors because they align staff incentives with company performance like a bonus tied to results, but they can also increase the number of shares outstanding and dilute existing shareholders’ ownership and per‑share earnings.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Martin Aaron

(Last) (First) (Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE KENTUCKY 40202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Medicare Advantage

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Humana Common	05/01/2026		A		8,206	A	$0	25,237(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 25,237 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

	Aaron Martin	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Humana (HUM) executive Aaron Martin report in this Form 4 filing?

Aaron Martin reported receiving a grant of 8,206 shares of Humana common stock. This was a compensation-related award, not an open-market purchase, and is recorded at $0.0000 per share under Humana’s stock incentive plans.

How many Humana (HUM) shares does Aaron Martin hold after this transaction?

After the transaction, Aaron Martin holds 25,237 restricted stock units. Each unit represents a contingent right to receive one share of Humana Inc. common stock, issued under the company’s 2019 and 2026 Stock Incentive Plans.

Was the Humana (HUM) Form 4 transaction an open-market buy or a compensation grant?

The Form 4 reflects a compensation grant, not an open-market buy. The 8,206 shares were acquired with a transaction code A, meaning a grant or award, and were priced at $0.0000 per share in the filing.

What type of securities did Aaron Martin receive from Humana (HUM)?

Aaron Martin received restricted stock units linked to Humana common stock. The filing notes 25,237 restricted stock units in total, each giving a contingent right to one Humana share under the company’s stock incentive plans.

Under which plans were Aaron Martin’s Humana (HUM) restricted stock units granted?

The restricted stock units were granted under Humana Inc.’s 2019 Amended & Restated and 2026 Stock Incentive Plans. The filing also states the awards are exempt under Rule 16b-3(d)(1)&(3) for executive compensation-related equity grants.